GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poltreg SA (WAR:PTG) » Definitions » EV-to-EBIT

Poltreg (WAR:PTG) EV-to-EBIT : -8.42 (As of May. 27, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Poltreg EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Poltreg's Enterprise Value is zł132.08 Mil. Poltreg's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was zł-15.68 Mil. Therefore, Poltreg's EV-to-EBIT for today is -8.42.

The historical rank and industry rank for Poltreg's EV-to-EBIT or its related term are showing as below:

WAR:PTG' s EV-to-EBIT Range Over the Past 10 Years
Min: -157.6   Med: -19.26   Max: -6.49
Current: -8.42

During the past 6 years, the highest EV-to-EBIT of Poltreg was -6.49. The lowest was -157.60. And the median was -19.26.

WAR:PTG's EV-to-EBIT is ranked worse than
100% of 476 companies
in the Biotechnology industry
Industry Median: 8.245 vs WAR:PTG: -8.42

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Poltreg's Enterprise Value for the quarter that ended in Mar. 2025 was zł130.20 Mil. Poltreg's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was zł-15.68 Mil. Poltreg's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was -12.04%.


Poltreg EV-to-EBIT Historical Data

The historical data trend for Poltreg's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poltreg EV-to-EBIT Chart

Poltreg Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial - - -49.67 -78.65 -13.72

Poltreg Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.72 -14.43 -11.27 -11.94 -8.30

Competitive Comparison of Poltreg's EV-to-EBIT

For the Biotechnology subindustry, Poltreg's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Poltreg's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poltreg's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Poltreg's EV-to-EBIT falls into.


;
;

Poltreg EV-to-EBIT Calculation

Poltreg's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=132.083/-15.678
=-8.42

Poltreg's current Enterprise Value is zł132.08 Mil.
Poltreg's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-15.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Poltreg  (WAR:PTG) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Poltreg's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2025 ) =EBIT / Enterprise Value (Q: Mar. 2025 )
=-15.678/130.202
=-12.04 %

Poltreg's Enterprise Value for the quarter that ended in Mar. 2025 was zł130.20 Mil.
Poltreg's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-15.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Poltreg EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Poltreg's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Poltreg Business Description

Traded in Other Exchanges
N/A
Address
ul.Botaniczna 20, Gdansk, POL, 80-298
Poltreg SA is a biotechnology company at the clinical stage developing an innovative generation of medicines using T-regulatory cells (TREGS) in the treatment of autoimmune diseases.

Poltreg Headlines

No Headlines